"Future of pulse cell therapy" Guangzhou will hold the annual international biotechnology conference in August

[pharmaceutical Station exhibition report] for thousands of years, human beings have adopted biotechnology in agriculture, food, medicine and other fields The early biotechnology can even be traced back to ancient times, such as ancient Egyptians using yeast to make wine In recent years, modern biotechnology, represented by gene engineering, cell engineering, enzyme engineering and fermentation engineering, has developed rapidly, and is increasingly affecting and changing people's production and life style With the rapid development of car-t cell therapy related research, inspired by the successful cases of blood tumor, the use of car-t to treat solid tumor is also moving forward steadily in the huge challenge With the increasing attention of biomedical industry in this field, the number of clinical trials based on car-t cell therapy continues to increase In 2018, nearly 300 clinical trials of car-t cell therapy for cancer treatment were registered on the website of clinicaltrials.gov in the United States Recently, car-t cell therapy technology of six domestic enterprises, such as borrida biology, pregene biology, Keji biology, Eureka biology and Hengrui Yuanzheng, has entered the clinical trial stage It can be seen that car-t cell therapy for blood tumor is still hot, and many cell therapy methods will challenge solid tumor Gather industry concerns and organize multiple theme meetings In order to further publicize the Expo, the Organizing Committee held a number of pre exhibition tours in Guangzhou, Shenzhen, Zhuhai and other places, which attracted a group of matching audiences for the conference in August During the pre exhibition technical lectures, the organizing committee sent 300 questionnaires to collect and analyze the audience's attention direction to the conference topics Through the summary and analysis of the questionnaires of these meetings, we can know the antibody Cell therapy is still a hot topic in recent years   It is precisely because the hot topics of antibody and cell therapy have attracted the attention of people in the industry that the organizing committee has specially set up related topics and held 7 series of special seminars, including the summit on antibody drugs and new drugs research and development and the summit on cell immunotherapy, which will focus on the development status and opportunities of China's biopharmaceutical industry and the humanization of gene editors Mouse technology and antibody diversity solutions, new progress of nano antibody platform drugs, detection methods and quality control standards of monoclonal antibody biological products, innovative pre clinical safety evaluation strategies of antibody drugs, etc   At that time, there will be a large number of experts to form a luxury guest list of speakers, including Dr Shi Jinhai, Secretary General of China protein drug quality alliance, Dr Gao Xu, director of Heilongjiang Basic Medical Research Institute, Dr Li Shenghua, biological scientist of prekin, Dr Tian Wenzhi, chairman of yimingongke biomedical Technology (Shanghai) Co., Ltd., Dr Wang Shaoxiong, executive officer of Bowei biological company, Jiangsu Province Dr Qiu Zhihua, deputy general manager of new drug R & D Department of Tsuen Xin biomedical Co., Ltd., Dr Zhang Xiaodong, vice president of preclinical toxicology of Shanghai medixi biomedical drugs, Dr Zheng Xiaohong, operating officer of Yantai Mai Bairui international biomedical Co., Ltd., Dr Han Weidong, director of biotherapy section of 301 Hospital, Dr Qian Cheng, director of biotherapy section of Southwest Hospital of Chongqing Army Medical University, etc People from national government agencies, executives from pharmaceutical companies at home and abroad, biotechnology companies and new drug R & D experts came to the scene to "feel" the future of cell therapy in China The Expo has been recommended by industry insiders as an extremely important business communication and industrial application docking platform in the field of biotechnology in Guangzhou and the whole country BTE, the annual international biotechnology conference of liangxiangsheng Expo for domestic and foreign brand enterprises Guangzhou International Biotechnology Expo 2019 (hereinafter referred to as the "bio Expo") is scheduled to be held in the exhibition hall of Guangzhou Canton Fair from August 30 to September 1, 2019 The bio Expo has four special areas, namely, biopharmaceutical, biological diagnosis and analysis, gene technology, biological fermentation and cell therapy At present, it has been fully supported by more than 200 relevant enterprises It is worth noting that a number of domestic and foreign advanced brand enterprises emerged in the exhibition, such as aibokang, xinbosheng, inshore technology, solabo, general biology, Yiqiao Shenzhou, intsaines, bevinger, Aosheng, biotechnology, kezhongyuan innovation, etc entered the conference early, carrying antibiosis, IVD raw materials, gene synthesis, protein expression and purification, DNA sequencing, gene editing technology, instrument With the appearance of equipment and related products, the Expo provides a comprehensive platform for enterprises in the industry to find advanced suppliers for new technologies, products and solutions The organizing committee always puts the effectiveness of exhibitors first Through various practical and effective ways to fully invite professional buyers including domestic and foreign Biopharmaceutical Enterprises, R & D enterprises, medical institutions, laboratories, scientific research institutes, colleges and universities, association member units, and carry out targeted core buyer invitation work according to the needs of exhibitors In order to facilitate the registration of visitors, the organizing committee has opened a fast registration channel At present, the number of visitors has exceeded 8000 Next, the organizing committee will further connect with major industrial parks in Shanghai Zhangjiang, Suzhou nanotechnology Park, Zhuhai Jinwan, Dongguan Songshan Lake, Shenzhen and other places It is expected to cover more than 5000 Biotechnology R & D, manufacturing and application enterprises , more than 20000 matching purchasers Contact information can be found below